SkyView Investment Advisors’s Bio-Techne TECH Stock Holding History

SkyView Investment Advisors’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-8	Closed	-$1K	–	747
2023 Q2	$1K	Buy	8 +4	+100%	+$322	﹤0.01%	728
2023 Q1	$0	Buy	+4	New	+$308	﹤0.01%	776

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SkyView Investment Advisors's TECH Position: Q3 2023 in Review

SkyView Investment Advisors sold out of Bio-Techne (TECH) in Q3 2023, closing a stake of 8 shares — an estimated $1K sold.

SkyView Investment Advisors first reported a position in TECH in Q1 2023 and held it in 2 quarters. The position peaked at $1K in Q2 2023. 529 funds tracked by Wall St. Rank hold TECH as of Q3 2023.

SkyView Investment Advisors reported no remaining Bio-Techne position as of Q3 2023 after selling out during the quarter.
SkyView Investment Advisors sold 8 Bio-Techne shares in Q3 2023, an estimated $1K.
SkyView Investment Advisors first reported a position in Bio-Techne in Q1 2023 and held it in 2 quarters.
SkyView Investment Advisors's Bio-Techne position peaked at $1K in Q2 2023.
529 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2023.

Based on SkyView Investment Advisors's 13F filing for Q3 2023, filed 17 Nov 2023.